Annual Drug Patent Expirations for ONPATTRO
Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug.
Drug patent litigation for ONPATTRO.
This drug has three hundred and six patent family members in thirty-three countries.
The generic ingredient in ONPATTRO is patisiran sodium. One supplier is listed for this compound. Additional details are available on the patisiran sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
